Bourgeon Capital Management’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3
| Closed | -$16 | – | 209 |
|
|
2023
Q4 | $16 | Hold |
3
| – | – | ﹤0.01% | 399 |
|
|
2023
Q3 | $22 | Hold |
3
| – | – | ﹤0.01% | 395 |
|
|
2023
Q2 | $102 | Hold |
3
| – | – | ﹤0.01% | 327 |
|
|
2023
Q1 | $214 | Hold |
3
| – | – | ﹤0.01% | 306 |
|
|
2022
Q4 | $250 | Hold |
3
| – | – | ﹤0.01% | 353 |
|
|
2022
Q3 | $0 | Hold |
3
| – | – | ﹤0.01% | 396 |
|
|
2022
Q2 | $0 | Hold |
3
| – | – | ﹤0.01% | 293 |
|
|
2022
Q1 | $1K | Hold |
3
| – | – | ﹤0.01% | 274 |
|
|
2021
Q4 | $1K | Hold |
3
| – | – | ﹤0.01% | 257 |
|
|
2021
Q3 | $1K | Hold |
3
| – | – | ﹤0.01% | 268 |
|
|
2021
Q2 | $2K | Hold |
3
| – | – | ﹤0.01% | 263 |
|
|
2021
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 258 |
|
|
2020
Q4 | $2K | Hold |
3
| – | – | ﹤0.01% | 247 |
|
|
2020
Q3 | $2K | Hold |
3
| – | – | ﹤0.01% | 254 |
|
|
2020
Q2 | $2K | Hold |
3
| – | – | ﹤0.01% | 235 |
|
|
2020
Q1 | $2K | Hold |
3
| – | – | ﹤0.01% | 239 |
|
|
2019
Q4 | $3K | Hold |
3
| – | – | ﹤0.01% | 218 |
|
|
2019
Q3 | $2K | Buy |
+3
| New | +$2K | ﹤0.01% | 223 |
|